Novonesis (Novozymes) A/S B
Novonesis (Novozymes) A/S B/ DK0060336014 /
NSIS/B
29/08/2024 16:59:33
|
Chg.
+5.10
|
Volume |
Bid17:10:00 |
Ask17:10:00 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
467.20DKK
|
+1.10%
|
578,341 Turnover: 261.61 mill. |
467.00Bid Size: 45 |
468.20Ask Size: 463 |
129.56 bill.DKK |
0.90% |
42.78 |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
CEO |
Ester Baiget |
Management board |
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
Supervisory board |
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
Name: |
Novozymes A.S |
Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
Phone: |
+45-44-460000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.novozymes.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
31/12 |
Free Float: |
74.50% |
IPO date: |
20/11/2000 |